PATENT CLAIM ANALYSIS

Application Number: 15897030
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "04400R"]

Abstract:
This document provides methods and materials for treating diabetes. For example, methods and materials for using nucleic acid encoding human preproinsulin to treat diabetes (e.g., type I or type II diabetes) are provided.

Claim (Index 7):
The method of  claim 1 , wherein said insulin polypeptide is a proinsulin polypeptide.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15524784', '11756821', '15888948', '14296404', '13809777']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6790052928664672
- 35 USC 102 Novelty (BERT): 0.5026395598502698
- Combined Prediction Score: 0.6613687195648474
- Mean Citation Score: 216.79959
- Max Citation Score: 223.11224
- Similarity Product: 152.88380237670427

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test